Miria Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Miria Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-463,900	Closed	-$7.02M	–	8
2022 Q3	$7.02M	Buy	+463,900	New	+$5.39M	25.22%	2

Miria Asset Management's AERI Position: Q4 2022 in Review

Miria Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 463,900 shares — an estimated $7.02M sold.

Miria Asset Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $7.02M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Miria Asset Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Miria Asset Management sold 463,900 Aerie Pharmaceuticals shares in Q4 2022, an estimated $7.02M.
Miria Asset Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Miria Asset Management's Aerie Pharmaceuticals position peaked at $7.02M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Miria Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.